Massachusetts officials have finalized regulations that will limit the growth of health insurance deductibles and copays to 3.6% in 2027. The move is aimed at controlling the rising out-of-pocket costs that individuals and businesses face for health coverage in the state. Under the new rules, health insurers will be prohibited from increasing cost-sharing measures—such as…
Healthcare expenditures in Massachusetts increased by 5.7% in 2024, according to recent data, marking the fourth consecutive year that spending has surpassed the state’s established benchmark. The growth in costs was primarily attributed to rising prices in the pharmaceutical and hospital sectors. These two areas were identified as the main drivers behind the continued escalation…
Generate Biomedicines, a Somerville-based company specializing in AI-driven drug development, has completed a $400 million initial public offering (IPO). The offering matches the record for the largest biotech IPO set in 2020, signaling renewed activity in the sector after a period of limited public offerings. The company’s successful entry into the public markets is being…
Framingham-based healthcare firm Alira Health is facing legal action from two founders whose companies were previously acquired by the firm. The lawsuits allege that Alira Health’s CEO misrepresented the company’s financial condition and plans for an initial public offering (IPO) prior to the acquisitions. According to the complaints, the two founders claim they were provided…
